Company Search:
Advanced Search
Sponsored Links
Biomerieux SA Company Snapshot
Biomerieux SA operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biomerieux SA with three other pharmaceutical manufacturers in Europe: Ipsen SA (2016 sales of 1.67 billion Euro [US$2.04 billion] of which 76% was Specialty Care), Stada Arzneimittel AG of Germany (2.14 billion Euro [US$2.61 billion] of which 60% was Generics), and H. Lundbeck A/S which is based in Denmark (15.63 billion Danish Kroner [US$2.56 billion] of which 19% was Other Pharmaceuticals).

Sales Analysis. Biomerieux SA reported sales of 2.10 billion Euro (US$2.56 billion) for the year ending December of 2016. This represents an increase of 7.1% versus 2015, when the company's sales were 1.96 billion Euro. Sales at Biomerieux SA have increased during each of the previous five years (and since 2011, sales have increased a total of 47%). Sales of Biofire Defense saw an increase that was more than double the company's growth rate: sales were up 41.9% in 2016, from 24.80 million Euro to 35.20 million Euro. Not all segments of Biomerieux SA experienced an increase in sales in 2016: sales of Co-Development Program fell 5.9% to 6.40 million Euro. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biomerieux SA
  Stock Performance Chart for Biomerieux SA
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 77.60
(Figures in Euro)
1 Week -2.1%   13 Weeks 4.7%  
4 Weeks 14.6%   52 Weeks 53.4%  
Biomerieux SA Key Data:
  Ticker: BIM Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 2,103,200,000
(Year Ending Jan 2017).
Employees: 9,806
  Currency: Euro Market Cap: 9,182,973,859
  Fiscal Yr Ends: December Shares Outstanding: 118,337,292
  Share Type: Actions Ordinaires Closely Held Shares: 76,330,050
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.